GAMMA Investing LLC Acquires 12,437 Shares of Colgate-Palmolive Company $CL

GAMMA Investing LLC increased its position in Colgate-Palmolive Company (NYSE:CL) by 114.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,329 shares of the company’s stock after buying an additional 12,437 shares during the period. GAMMA Investing LLC’s holdings in Colgate-Palmolive were worth $1,843,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Copia Wealth Management bought a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $29,000. Vermillion & White Wealth Management Group LLC lifted its position in shares of Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after buying an additional 155 shares during the last quarter. Cloud Capital Management LLC bought a new position in Colgate-Palmolive during the third quarter worth about $30,000. Global Wealth Strategies & Associates increased its stake in shares of Colgate-Palmolive by 300.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after purchasing an additional 300 shares in the last quarter. Finally, Kelleher Financial Advisors bought a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $35,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL opened at $85.14 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. The stock has a market capitalization of $68.62 billion, a P/E ratio of 32.49, a PEG ratio of 3.83 and a beta of 0.28. The stock has a 50-day moving average price of $91.01 and a 200-day moving average price of $83.37. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter in the previous year, the company posted $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 5.8% compared to the same quarter last year. Equities analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be given a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Monday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider John Hazlin sold 20,989 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the transaction, the insider owned 17,645 shares in the company, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the sale, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 184,683 shares of company stock valued at $17,486,693. Company insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the subject of a number of recent research reports. UBS Group lifted their price objective on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research note on Wednesday, January 14th. Royal Bank Of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a report on Tuesday, December 9th. Morgan Stanley upped their price target on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Piper Sandler boosted their price objective on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Eleven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.